HIMSS Analytics Honors Yale New Haven Hospital With Stage 7 Award

Thursday, October 1, 2015

CHICAGO (October 1, 2015) - HIMSS Analytics awarded Yale New Haven Hospital (YNHH), in New Haven, Conn., with a Stage 7Award. The award represents YNHH’s attainment of the highest level on the Electronic Medical Record Adoption Model™ (EMRAM).

HIMSS Analytics developed the EMR Adoption Model in 2005 as a methodology for evaluating the progress and impact of electronic medical record systems for hospitals in the HIMSS Analytics™ Database. There are eight stages (0-7) that measure a hospital’s implementation and utilization of information technology applications. The final stage, Stage 7, represents an advanced patient record environment. The validation process to confirm a hospital has reached Stage 7 includes a site visit by an executive from HIMSS Analytics and former or current chief information officers to ensure an unbiased evaluation of the Stage 7 environments.

During the second quarter of 2015, only 3.7 percent of the more than 5,400 U.S. hospitals in the HIMSS Analytics® Database received the Stage 7 Award.

“We are honored to receive this recognition,” said Thomas Balcezak, MD, chief medical officer Yale New Haven Hospital. “It shows our commitment to using technology in every aspect of our operations from bedside care to business intelligence. Fully adopting the EHR, helps us to provide highly reliable, safer, better care to patients every day.”

YNHH, part of Yale New Haven Health System, is a nationally recognized, 1,541-bed, not-for-profit hospital serving as the primary teaching hospital for the Yale School of Medicine. Yale New Haven was founded as the fourth voluntary hospital in the U.S. in 1826 and today, the hospital’s two New Haven-based campuses include Yale New Haven Children's Hospital, Yale New Haven Psychiatric Hospital and Smilow Cancer Hospital.

“It was clear from my visit to Yale New Haven Hospital that they are serious about their mission, vision and values,” said John H. Daniels, CNM, FACHE, FHIMSS, CPHIMS, global vice president, healthcare advisory services group, HIMSS Analytics. “They are leveraging their EHR technology in very innovative ways. They are saving time and improving the patient experience through radiology protocolling using the EHR; their eICU has proven its value particularly when caring for patients in isolation; research recruitment is integrated in the patient portal; and they have proven the value of clinical decision support evidenced by their smoking cessation protocol compliance project. Stage 7 designation is well deserved!”

Yale New Haven Hospital will be recognized at the 2016 Annual HIMSS Conference & Exhibition on Feb. 29-March 4, 2016, in Las Vegas, Nev.

Visit the HIMSS Analytics website for more information on the Stage 7 Award.

About HIMSS Analytics

HIMSS Analytics collects, analyzes and distributes essential health IT data related to products, costs, metrics, trends and purchase decisions. It delivers quality data and analytical expertise to healthcare delivery organizations, IT companies, governmental entities, financial, pharmaceutical and consulting companies. Visit www.himssanalytics.org.

HIMSS Analytics is a part of HIMSS, a cause-based, global enterprise that produces health IT thought leadership, education, events, market research and media services around the world. Founded in 1961, HIMSS encompasses more than 52,000 individuals, of which more than two-thirds work in healthcare provider, governmental and not-for-profit organizations across the globe, plus over 600 corporations and 250 not-for-profit partner organizations, that share the cause of transforming health and healthcare through the best use of IT. HIMSS, headquartered in Chicago, serves the global health IT community with additional offices in the United States, Europe, and Asia.

###

Yale New Haven Hospital (YNHH), part of Yale New Haven Health, is a nationally recognized, 1,541-bed, not-for-profit hospital serving as the primary teaching hospital for the Yale School of Medicine (YSM). Founded as the fourth voluntary hospital in the U.S. in 1826, today, YNHH has two New Haven-based campuses, and also includes Yale New Haven Children's Hospital, Yale New Haven Psychiatric Hospital and Smilow Cancer Hospital. YNHH has received Magnet designation from the American Nurses Credentialing Center, the nation’s highest honor of nursing excellence. YNHH has a combined medical staff of about 4,500 university and community physicians practicing in more than 100 specialties. www.ynhh.org

Similar Articles

12/10/19

Yale New Haven Health CEO Marna P. Borgstrom recognized as one of the 100 Most Influential People by Modern Healthcare

New Haven, CT (Dec. 10, 2019) – Marna P. Borgstrom, CEO Yale New Haven Health System (YNHHS) and Yale New Haven Hospital, has been recognized by Modern Healthcare as one of 100 Most Influential People.

11/25/19

Smilow Cancer Hospital receives re-accreditation by the Commission on Cancer

New Haven, CT (Nov. 25, 2019) – The Commission on Cancer (CoC), a quality program of the American College of Surgeons (ACoS), has granted three-year accreditation with commendation to the cancer program at Smilow Cancer Hospital (SCH) at Yale New Haven.

10/29/19

Smilow Cancer Hospital Care Center opens at Westerly Hospital

Westerly, RI (October 29, 2019) – Westerly Hospital celebrated the opening of its new Smilow Cancer Hospital Care Center Monday, the second new unit to open at the hospital in as many months.